A retrospective study on the efficacy and safety of amphotericin B in a lipid emulsion for the treatment of cryptococcal meningitis in AIDS patients
- 1 July 1998
- journal article
- Published by Elsevier in Journal of Infection
- Vol. 37 (1) , 36-38
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Randomized Comparison of Amphotericin B Deoxycholate Dissolved in Dextrose or Intralipid for the Treatment of AIDS-Associated Cryptococcal MeningitisClinical Infectious Diseases, 1996
- Amphotericin B in a lipid emulsion for the treatment of cryptococcal meningitis in AIDS patientsJournal of Antimicrobial Chemotherapy, 1996
- Amphotericin B does not mix with fat emulsionAmerican Journal of Health-System Pharmacy, 1995
- Cryptococcal Meningitis and AIDSClinical Infectious Diseases, 1993
- Management of CryptococcosisClinical Infectious Diseases, 1993
- Efficacy and tolerance of an amphotericm B lipid (Intralipid) emulsion in the treatment of candidaemia in neutropenic patientsJournal of Antimicrobial Chemotherapy, 1993
- Trial of glucose versus fat emulsion in preparation of amphotericin for use in HIV infected patients with candidiasis.BMJ, 1992
- Reduced renal toxicity and improved clinical tolerance of amphotericin B mixed with Intralipid compared with conventional amphotericin B in neotropenic patientsJournal of Antimicrobial Chemotherapy, 1992
- Amphotericin B: 30 Years of Clinical ExperienceClinical Infectious Diseases, 1990
- An Emulsion Formulation of Amphotericin B Improves the Therapeutic Index When Treating Systemic Murine CandidiasisThe Journal of Infectious Diseases, 1988